Déjanos tus datos y te asesoraremos totalmente GRATIS
Spanish retail market in past decade and the rise of ecommerce
Retail sales in Spain 
Spain’s current ecommerce environment
Future outlook and possible investment opportunities
Singapore’s “Home” strategy
The attractiveness of doing business in Singapore
The “Home” strategy applied
The rise of renewable energy in Spain
Current developments of wind energy
Effects on economy and future outlook
FinTech investment in Spain (USD, number of deals). 2014-2017
About the author:
About the author:
Farmaindustria, the Spanish association of pharmaceutical industries, has recently published an analysis showing that the Spanish public pharmaceutical expenditure has decreased without sacrificing innovation. The latest data shows that, although the public healthcare sector is not spending as much on pharmaceuticals as in 2010, innovative medicines still reach the patients. Pharmaceutical expenditure represented a 1.43% of the GDP in 2017, lower than the 1.57% of 2010. This is possible thanks to the price pressure after a patent expires and generics appear in the market, this is known as reference pricing. Currently, 8 out of 10 pharmaceuticals consumed are generics and they represent 55% of the Spanish pharmaceuticals market. Furthermore, the pharmaceutical industry has a low success rate, with only 11.8% of the compounds reaching the market and being approved by the healthcare authorities.
Figure 1. Total pharmaceutical expenditure over the years (2010-2017)
Source: adapted from graphic from Farmaindustria
Figure 2. Percentage of the Regional Domestic Gross invested in healthcare expenditure. 2016
In a previous post titled How to bring a foreign company to Spain, Dos Aguas Team discussed the three most common ways to start a company in Spain: a Representative Office, Subsidiary or a Branch Company. Being these three the famous and regular ones, in this blog, we would also like to introduce another formula that can be as effective and beneficial as the other three: the Joint Venture.
Separate paragraph for an analysis of commercial and financial risk of non-Spanish institutions. The levels of risk they present are lower than their national peers: 29% have a high or medium-high risk compared to 36% of Spanish companies, while 71% of foreign companies have low or medium-low risk levels, compared to 64% of Spanish companies.
The vast majority of foreign investors agree that Spain has many clear advantages when it comes to settling in: the flexibility and adaptability of economic operators, the quality of life offered by the country, its cultural proximity to Latin America (where several Spanish multinationals are located), the rise of tourism, the efficiency of its transport network and the development of renewable energy. As an incentive for the future, Spain aspires to become one of the world’s leading research players.
The other side of the coin is the obstacles of the Spanish administration: the complexity of starting a new company, and the lack of relevance of the Spanish market compared to other Western countries. We would need several more pages to analyze the complexity of the Spanish legislative system, due to the presence of 17 Autonomous Communities (comparable to the American states, the Italian regioni or the German Länder), which is also an obstacle to investment.
After a brief analysis of all the factors, we can conclude that Spain undoubtedly has unique and attractive characteristics that make it an unavoidable destination for foreign investment.